Posts tagged valproate
Articles and news from the latest research reports.
Epilepsy drug turns out to help adults acquire perfect pitch and learn language like kids
A team of researchers from across the globe believe they have discovered a means of re-opening “critical periods” in brain development, allowing adults to acquire abilities — such as perfect pitch or fluency in language — that could previously only be acquired early in life.
According to the study in Frontiers in Systems Neuroscience, the mood-stabilizing drug valproate allows the adult brain to absorb new information as effortlessly as it did during critical windows in childhood.
A critical period is “a fixed window of time, usually early in an organism’s lifespan, during which experience has lasting effects on the development of brain function and behavior.” They are, for example, what allows children to enter into language without any formal training in grammar or vocabulary.
The researchers postulated that because such periods close when enzymes “impose ‘brakes’ on neuroplasticity,” a drug that blocks the productions of those enzymes might be able to “reopen critical-period neuroplasticity.”
Important breakthrough in identifying the effect of epilepsy treatment
50 years after valproate was first discovered, research published today in the journal Neurobiology of Disease, reports how the drug works to block seizure progression.
Valproate (variously labelled worldwide as Epilim, Depacon, Depakene, Depakote, Orlept, Episenta, Orfiril, and Convulex) is one of the world’s most highly prescribed treatments for epilepsy. It was first discovered to be an effective treatment for epilepsy, by accident, in 1963 by a group of French scientists. In thousands of subsequent experiments, animals have been used to investigate how valproate blocks seizures, without success. Scientists from Royal Holloway and University College London have now identified how valproate blocks seizures in the brain, by using a simple amoeba.
“The discovery of how valproate blocks seizures, initially using the social amoeba Dictyostelium, and then replicated using accepted seizure models, highlights the successful use of non-animal testing in biomedical research,” said Professor Robin Williams from the School of Biological Sciences at Royal Holloway.
“Sodium valproate is one of the most effective antiepileptic drugs in many people with epilepsy, but its use has been limited by side-effects, in particular its effect in pregnant women on the unborn child,” said Professor Matthew Walker from the Institute of Neurology at University College London. “Understanding valproate’s mechanism of action is a first step to developing even more effective drugs that lack many of valproate’s side-effects.
“Our study also found that the decrease of a specific chemical in the brain at the start of the seizure causes even more seizure activity. This holds important implications for identifying underlying causes,” added Professor Williams.
(Source: rhul.ac.uk)